Edwards Lifesciences Corp (EW)
92.85
+0.54
(+0.58%)
USD |
NYSE |
Mar 18, 16:00
92.99
+0.14
(+0.15%)
Pre-Market: 09:06
Edwards Lifesciences Price: 92.85 for March 18, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Mar 18, 2024 | 92.48 | 93.04 | 91.95 | 92.85 | 2.554M |
Mar 15, 2024 | 92.46 | 94.00 | 92.16 | 92.31 | 5.700M |
Mar 14, 2024 | 93.03 | 95.27 | 92.47 | 93.36 | 5.067M |
Mar 13, 2024 | 90.91 | 93.30 | 90.09 | 92.93 | 7.036M |
Mar 12, 2024 | 90.58 | 91.15 | 89.79 | 90.91 | 2.324M |
Mar 11, 2024 | 91.73 | 92.04 | 90.70 | 90.83 | 2.974M |
Mar 08, 2024 | 93.34 | 94.20 | 91.91 | 92.14 | 5.909M |
Mar 07, 2024 | 90.98 | 93.89 | 90.74 | 93.81 | 6.847M |
Mar 06, 2024 | 86.43 | 88.65 | 86.28 | 88.33 | 3.552M |
Mar 05, 2024 | 86.79 | 87.40 | 85.66 | 86.10 | 2.226M |
Mar 04, 2024 | 85.36 | 87.59 | 85.32 | 87.02 | 6.773M |
Mar 01, 2024 | 84.40 | 85.74 | 83.61 | 85.22 | 3.296M |
Feb 29, 2024 | 86.00 | 86.03 | 84.43 | 84.87 | 5.175M |
Feb 28, 2024 | 86.32 | 86.62 | 85.48 | 86.00 | 2.635M |
Feb 27, 2024 | 86.12 | 86.72 | 85.41 | 86.51 | 4.070M |
Feb 26, 2024 | 87.39 | 87.73 | 85.84 | 86.15 | 6.366M |
Feb 23, 2024 | 87.92 | 88.33 | 87.37 | 87.74 | 2.798M |
Feb 22, 2024 | 86.36 | 87.76 | 85.49 | 87.62 | 2.461M |
Feb 21, 2024 | 87.02 | 87.16 | 86.20 | 86.65 | 2.142M |
Feb 20, 2024 | 85.80 | 87.00 | 85.30 | 86.90 | 3.236M |
Feb 16, 2024 | 85.84 | 87.25 | 85.43 | 86.10 | 2.122M |
Feb 15, 2024 | 86.30 | 86.71 | 85.38 | 86.04 | 2.727M |
Feb 14, 2024 | 86.62 | 87.28 | 85.03 | 86.04 | 4.977M |
Feb 13, 2024 | 86.00 | 87.48 | 85.30 | 86.26 | 4.013M |
Feb 12, 2024 | 84.83 | 87.47 | 84.44 | 87.12 | 3.826M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
52.41
Minimum
Mar 23 2020
130.68
Maximum
Dec 30 2021
85.35
Average
81.72
Median
Mar 05 2021
Price Benchmarks
Boston Scientific Corp | 67.24 |
Stryker Corp | 354.08 |
Align Technology Inc | 316.32 |
Zimmer Biomet Holdings Inc | 125.96 |
Abbott Laboratories | 112.44 |
Price Related Metrics
PE Ratio | 40.37 |
PS Ratio | 9.423 |
Price to Book Value | 8.396 |
Price to Free Cash Flow | 89.89 |
Earnings Yield | 2.48% |
Market Cap | 55.83B |
Operating PE Ratio | 32.71 |
Normalized PE Ratio | 36.22 |